Fulminant Marginal Keratitis Induced by Atezolizumab, a Programmed Death Ligand 1 Inhibitor for Lung Cancer

INTRODUCTION: With the increasing use of immune checkpoint inhibitors, ocular adverse events have gained attention. We describe a case of atypical keratitis presumably induced by atezolizumab, a programmed cell death ligand 1 inhibitor. CASE PRESENTATION: A 73-year-old Japanese woman developed ring-...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Masashi, Yamada, Masakazu, Kusumi, Yumi, Fukui, Masaki, Shigeyasu, Chika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697742/
http://dx.doi.org/10.1159/000535077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697742/
http://dx.doi.org/10.1159/000535077

Ejemplares similares